FDA NDC Directory · JSON-LD · Markdown

Buprenorphine and Naloxone

NDC 70518-3389 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerREMEDYREPACK INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA205601
Dosage form / routeTABLET · SUBLINGUAL
Active ingredientsBUPRENORPHINE HYDROCHLORIDE (8 mg/1)
NALOXONE HYDROCHLORIDE DIHYDRATE (2 mg/1)
Marketing started20220316
Package count1

External sources

Source: openFDA. Public-domain (CC0).